MLTX — MoonLake Immunotherapeutics stock price, charts and financials

QT17MoonLake Immunotherapeutics

MoonLake Immunotherapeutics (NASDAQ: MLTX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
17.93
+0.53+3.05%
OverviewShort InterestFilings
MLTXQT17MoonLake Immunotherapeutics·NASDAQ
17.93+3.05%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 29, 20264Statement of changes in beneficial ownership
Jul 23, 20264Statement of changes in beneficial ownership
Jul 21, 20264Statement of changes in beneficial ownership
Jul 20, 20264Statement of changes in beneficial ownership
Jul 15, 20268-KCurrent report
Jul 13, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 29, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jun 25, 20268-KCurrent report
Jun 24, 2026424B5Prospectus
Jun 23, 20264Statement of changes in beneficial ownership
Jun 22, 20268-KCurrent report
Jun 22, 2026424B5Prospectus
Jun 22, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 09, 20268-KCurrent report
Jun 01, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 13, 20264Statement of changes in beneficial ownership
May 11, 20268-KCurrent report
#1 / 25 of 264
Page
▼
/ 11